Posts in category

Columns


Different indicators give a varied picture of pharmacy customer experience, so which one is right? asks Glenn Guilfoyle  A recent edition of the Pharmacy Guild of Australia’s newsletter Forefront featured …

Debbie Rigby takes a look at the latest in research news Improving the Management of COPD in Women Chronic obstructive pulmonary disease (COPD) is a highly debilitating disease that represents …

In the fourth of a series of interviews with the top five of our list of 10 Women of Influence in pharmacy, we speak to pharmacy academic Lisa Nissen 1. Do …

PPI use is increasing, writes Ben Basger—but what is its role long term? Do you think that when doctors decide to block the production of stomach acid by using a …

Review submission quantities reveal a somewhat disparate and divided profession, says Joe Demarte, PSA national president The many submissions responding to the Discussion Paper released by the Review of Pharmacy …

The latest in research news, as gathered by Debbie Rigby Pharmacokinetics and pharmacodynamics of sofosbuvir and ledipasvir for the treatment of hepatitis This article reviews the pharmacokinetic and pharmacodynamic properties …

Prescribing shouldn’t be our only focus when it comes to antibiotic resistance, writes Oscar Klass During Antibiotic Awareness Week the pharmacy profession will be reminded of the importance of antibiotics—how …

In the third of a series of interviews with the top five of our list of 10 Women of Influence in pharmacy, we speak to community pharmacy owner Elise Apolloni Do you …

With community pharmacy now directly involved in dispensing antiretrovirals, it’s more important than ever that pharmacists are up to speed on HIV, writes Louis Roller The acquired immune deficiency syndrome …

The launch of the Pharmacy Diabetes Screening Trial is a key step in progressing the Pharmacy Trial Program (PTP), says David Quilty, Pharmacy Guild executive director It is now 17 …

Debbie Rigby presents the latest in research news Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation In ARISTOTLE study, non-major bleeding was common and substantially less frequent …

In the second of a series of interviews with the top five of our list of 10 Women of Influence in pharmacy, we speak to Dr Alison Roberts, PSA Executive Director …